Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylene Glycol SCHEMBL6009699 | 0.90 | HSD17B10 (0.32) | — | |
| SCHEMBL20301478 | 0.89 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL248362 | 0.83 | — | — | |
| SCHEMBL5464884 | 0.80 | — | — | |
| SCHEMBL290836 | 0.80 | — | — | |
| SCHEMBL27253756 | 0.79 | — | — | |
| SCHEMBL929596 | 0.79 | — | — | |
| SCHEMBL5090272 | 0.78 | — | — | |
| SCHEMBL31053788 | 0.78 | HCRTR2 (0.33) | — | |
| SCHEMBL888005 | 0.78 | MEN1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110168038-B | Methyl menthol derivative and cold sensate composition containing same | 高砂香料工业株式会社 | 2022-05-27 | — | — | CN | claimed |
| WO-1998024455-A1 | INGESTIBLE PHARMACEUTICAL COMPOSITIONS FOR TREATING UPPER GASTROINTESTINAL TRACT DISTRESS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-11 | — | — | WO | claimed |
| EP-0616495-A4 | CHEWING GUM UTILIZING CODRIED 3-1-MENTHOXYPROPANE-1,2-DIOL. | WRIGLEY W M JUN CO (US) | 1995-02-01 | — | — | EP | claimed |
| EP-0616495-A1 | CHEWING GUM UTILIZING CODRIED 3-1-MENTHOXYPROPANE-1,2-DIOL. | WRIGLEY W M JUN CO (US) | 1994-09-28 | — | — | EP | claimed |
| US-5326574-A | Carrier; nonsoftening; cooling taste | WM. WRIGLEY JR. COMPANY (US) | 1994-07-05 | — | — | US | claimed |
| WO-1993011672-A1 | CHEWING GUM UTILIZING CODRIED 3-1-MENTHOXYPROPANE-1,2-DIOL | WM. WRIGLEY JR. COMPANY (US) | 1993-06-24 | — | — | WO | claimed |
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | COTY INC. | 2025-01-30 | — | — | US | disclosed |
| EP-4294848-A1 | OXIDIZED POLYSACCHARIDE DERIVATIVES | Nutrition & Biosciences USA 4, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20230350228-A1 | CONTACT LENS | COOPERVISION INTERNATIONAL LIMITED (GB) | 2023-11-02 | — | — | US | disclosed |
| EP-0662840-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING COLD SYMPTOMS | THE PROCTER & GAMBLE COMPANY (US) | 1995-07-19 | — | — | EP | disclosed |
| EP-0616495-A4 | CHEWING GUM UTILIZING CODRIED 3-1-MENTHOXYPROPANE-1,2-DIOL. | WRIGLEY W M JUN CO (US) | 1995-02-01 | — | — | EP | disclosed |
| EP-0616495-A1 | CHEWING GUM UTILIZING CODRIED 3-1-MENTHOXYPROPANE-1,2-DIOL. | WRIGLEY W M JUN CO (US) | 1994-09-28 | — | — | EP | disclosed |
| WO-1994020074-A1 | ADSORBATE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994008551-A2 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING COLD SYMPTOMS | THE PROCTER & GAMBLE COMPANY (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1993011672-A1 | CHEWING GUM UTILIZING CODRIED 3-1-MENTHOXYPROPANE-1,2-DIOL | WM. WRIGLEY JR. COMPANY (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0080148-B1 | 3-L-MENTHOXYPROPANE-1,2-DIOL | Takasago Perfumery Co., Ltd. (JP) | 1985-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | OR51E2, FDFT1, ELANE | PRMT1 4174/4885 |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | TRPA1, TRPV1, NAA40 | PRMT1 870/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | PRMT1 1612/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | PRMT1 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.